{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:49:49Z","timestamp":1789901389049,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1136\/ard.2010.134825","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T01:13:42Z","timestamp":1298423622000},"page":"1130-1137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membrane"],"prefix":"10.1016","volume":"70","author":[{"given":"Anne","family":"Crilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Alastair","family":"Gracie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard P","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F","family":"Life","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.134825_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis.","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1136\/ard.2010.134825_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis.","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2010.134825_bib3","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis.","volume":"118","author":"Brennan","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2010.134825_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/BOR.0b013e3282fa13ee","article-title":"Is there a future for small molecule drugs in the treatment of rheumatic diseases?","volume":"20","author":"Stanczyk","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2010.134825_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem J"},{"key":"10.1136\/ard.2010.134825_bib6","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.4049\/jimmunol.159.12.6253","article-title":"Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.","volume":"159","author":"Ross","year":"1997","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.134825_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-2999(00)00330-7","article-title":"Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis.","volume":"399","author":"Francischi","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1136\/ard.2010.134825_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2567.2004.01768.x","article-title":"Impact of cAMP on the T-cell response to type II collagen.","volume":"111","author":"Ozegbe","year":"2004","journal-title":"Immunology"},{"key":"10.1136\/ard.2010.134825_bib9","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.4049\/jimmunol.178.8.4820","article-title":"Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.","volume":"178","author":"Peter","year":"2007","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.134825_bib10","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.4049\/jimmunol.163.5.2836","article-title":"Regulation of IL-15-stimulated TNF-alpha production by rolipram.","volume":"163","author":"Kasyapa","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.134825_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)29287-9","article-title":"Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.","volume":"299","author":"Jimenez","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1136\/ard.2010.134825_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1523-1747.2003.12301.x","article-title":"Rolipram inhibits polarization and migration of human T lymphocytes.","volume":"121","author":"Layseca-Espinosa","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ard.2010.134825_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0026-895X(25)10530-0","article-title":"Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.","volume":"48","author":"Seldon","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1136\/ard.2010.134825_bib14","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/cc7158","article-title":"Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock.","volume":"12","author":"Link","year":"2008","journal-title":"Crit Care"},{"key":"10.1136\/ard.2010.134825_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(24)29537-9","article-title":"Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro.","volume":"297","author":"Hatzelmann","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1136\/ard.2010.134825_bib16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/thx.2006.075937","article-title":"Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.","volume":"62","author":"Grootendorst","year":"2007","journal-title":"Thorax"},{"key":"10.1136\/ard.2010.134825_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/intimm\/dxg079","article-title":"Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity.","volume":"15","author":"Heystek","year":"2003","journal-title":"Int Immunol"},{"key":"10.1136\/ard.2010.134825_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-540-72843-6_6","article-title":"PDE4 associates with different scaffolding proteins: modulating interactions as treatment for certain diseases.","volume":"186","author":"McCahill","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"10.1136\/ard.2010.134825_bib19","doi-asserted-by":"crossref","first-page":"R317","DOI":"10.1186\/ar999","article-title":"Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.","volume":"5","author":"Foey","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.134825_bib20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bmcl.2009.01.045","article-title":"Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration.","volume":"19","author":"Lunniss","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1136\/ard.2010.134825_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.134825_bib22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/eji.1830270308","article-title":"Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.","volume":"27","author":"Sebbag","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2010.134825_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5","article-title":"Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.","volume":"46","author":"Brennan","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.134825_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm0297-189","article-title":"Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis.","volume":"3","author":"McInnes","year":"1997","journal-title":"Nat Med"},{"issue":"Suppl 3","key":"10.1136\/ard.2010.134825_bib25","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1186\/ar558","article-title":"The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction.","volume":"4","author":"Burger","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.2010.134825_bib26","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/ar3041","article-title":"Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.","volume":"12","author":"McCann","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.134825_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/ard.2005.037176","article-title":"Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.","volume":"65","author":"Haringman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.134825_bib28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/art.20932","article-title":"Chemokines and their receptors in rheumatoid arthritis: future targets?","volume":"52","author":"Koch","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.134825_bib29","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/art.23591","article-title":"Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.","volume":"58","author":"Vergunst","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.134825_bib30","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","article-title":"IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.","volume":"67","author":"Emery","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.134825_bib31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/rheumatology\/kem257","article-title":"Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis.","volume":"47","author":"Emery","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.134825_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/ar385","article-title":"Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis.","volume":"4","author":"Foey","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.2010.134825_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI115338","article-title":"Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.","volume":"88","author":"Laff\u00f3n","year":"1991","journal-title":"J Clin Invest"},{"issue":"Suppl","key":"10.1136\/ard.2010.134825_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0896-8411(89)90129-7","article-title":"Cytokine production in culture by cells isolated from the synovial membrane.","volume":"2","author":"Brennan","year":"1989","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.2010.134825_bib35","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.4049\/jimmunol.166.4.2270","article-title":"Effector function of resting T cells: activation of synovial fibroblasts.","volume":"166","author":"Yamamura","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.134825_bib36","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2353\/ajpath.2007.070004","article-title":"Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.","volume":"171","author":"Tran","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2010.134825_bib37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/1381612053381945","article-title":"The role of synovial fibroblasts in mediating joint destruction in rheumatoid arthritis.","volume":"11","author":"Meinecke","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1136\/ard.2010.134825_bib38","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","article-title":"Mast cells express IL-17A in rheumatoid arthritis synovium.","volume":"184","author":"Hueber","year":"2010","journal-title":"J Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724101215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724101215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.134825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T22:39:21Z","timestamp":1740955161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724101215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0003496724101215"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.134825","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membrane","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.134825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}